Before the ACIP approves another Covid shot, watch how they approved Hep B shots in 2018
As the ACIP gears up to approve yet another COVID shot, let’s take a look behind the curtain.
Virginians for Medical Freedom has provided this clip from 2018 showing us how the Hepislav-B vaccine was approved, despite a myocardial infarction signal. (That’s a heart attack to you and me.)
Q: Is there any comment on using this vaccine at the same time with other adjuvanted vaccines?
CDC: We have no data to make a recommendation one way or another.
CDC (Amanda Cohn): So, just to sort of put this in context of other vaccines, while pre-clinical studies were not done using these vaccines simultaneously, our general approach to immunizations is that they should be given, that they can be given at the same time in different limbs.
Dr. Hunter: Are adjuvanted, multiple adjuvanted vaccines used in Europe or other markets?
CDC/Nana Bennett: Dr. Ward, do you want to comment?
Dr. Ward: Not to my knowledge.
CDC/Nana Bennett : Ok. Unless I think there’s any further discussion, we will take a vote… on this recommendation (Hepislav B)…
And thank you very much. Ok, voting is completed and it is unanimous to support this recommendation. I want to thank you all.
CDC/Amanda Cohn: And does anybody around the table… does anybody have any comments they wish to make about their vote?
Dr. Stephens: So just a slight reservation. I think this is a huge advance and a step forward. I am concerned about that signal. That myocardial infarction signal. I am concerned about the use of this new adjuvant and certainly urge us to continue to look at this post-marketing data carefully.
Dr. Hunter: Just a question about that. How soon would we be getting that post-marketing update here?
??: There’s two kinds of data. The vaccine safety datalink will require people to be using the vaccine to develop substantive database. And, Dr. Sun, do you want to comment on the post-marketing data that the FDA is requiring?
Dr. Sun: Um, I think for the myocardial infarction study, we’re… seeing that date is for likely for May 31, 2020. There will also be studies looking at autoimmune diseases as well as herpes zoster. And there will be a pregnancy registry as well. That’s all included in the post-marketing surveillance.
You can watch the full meeting here.
Now take a look at those “signals” Dr. Stephens had a “slight reservation” about in the Hepislav B package insert:
This is how the ACIP, the FDA and other regulatory authorities will continue to make decisions until we demand they do better.
Let’s make them do better. It looks like the ACIP is still accepting comments, but hurry!
Again, here’s the link: https://www.regulations.gov/commenton/CDC-2023-0060-0001
And here’s the webcast link to watch the meeting on September 12. Let’s not let these decisions take place in the shadows when no one’s watching.
Thank you for reading.
Same happened with Aspertame years ago. I recall Pres. Bush kicked two questionable voters off the committee and put 2 new ones of his own in and wham it was voted in although nobody knew anything about it. It takes very arrogent stupid people to take others lives into their own hands when they don't know what they are talking about. 😔
Good one.
We need to get this out there to those trusting in gov., oblivious people!!
Please pass this on!